ArticleCardiovascular diabetology2020

Major adverse cardiovascular and limb events in patients with diabetes and concomitant peripheral artery disease treated with sodium glucose cotransporter 2 inhibitor versus dipeptidyl peptidase-4 inhibitor.

Hsin-Fu Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.